GRPR/PI3Kγ: Partners in Central Transmission of Itch

J Neurosci. 2015 Dec 9;35(49):16272-81. doi: 10.1523/JNEUROSCI.2310-15.2015.

Abstract

The gastrin-releasing peptide (GRP) and its receptor (GRPR) are important components of itch transmission. Upstream, but not downstream, aspects of GRPR signaling have been investigated extensively. We hypothesize that GRPR signals in part through the PI3Kγ/Akt pathway. We used pharmacological, electrophysiological, and behavioral approaches to further evaluate GRPR downstream signaling pathways. Our data show that GRP directly activates small-size capsaicin-sensitive DRG neurons, an effect that translates into transient calcium flux and membrane depolarization (∼ 20 mV). GRPR activation also induces Akt phosphorylation, a proxy for PI3Kγ activity, in ex vivo naive mouse spinal cords and in GRPR transiently expressing HEK293 cells. The intrathecal injection of GRP led to intense scratching, an effect largely reduced by either GRPR antagonists or PI3Kγ inhibitor. Scratching behavior was also induced by the intrathecal injection of an Akt activator. In a dry skin model of itch, we show that GRPR blockade or PI3Kγ inhibition reversed the scratching behavior. Altogether, these findings are highly suggestive that GRPR is expressed by the central terminals of DRG nociceptive afferents, which transmit itch via the PI3Kγ/Akt pathway.

Significance statement: Itch is the most common symptom of the skin and is related to noncutaneous diseases. It severely impairs patients' quality of life when it becomes chronic and there is no specific or effective available therapy, mainly because itch pathophysiology is not completely elucidated. Our findings indicate that the enzyme PI3Kγ is a key central mediator of itch transmission. Therefore, we suggest PI3Kγ as an attractive target for the development of new anti-pruritic drugs. With this study, we take a step forward in our understanding of the mechanisms underlying the central transmission of itch sensation.

Keywords: AS605240; GRPR; PI3Kγ; dry skin; itch; spinal cord.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Anticarcinogenic Agents / therapeutic use
  • Bombesin / analogs & derivatives
  • Bombesin / therapeutic use
  • Capsaicin / toxicity
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism*
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Ganglia, Spinal / cytology
  • Gastrin-Releasing Peptide / metabolism*
  • Indoles / pharmacology
  • Male
  • Mice
  • Neurons / drug effects
  • Neurons / physiology
  • Pain Threshold / drug effects
  • Peptide Fragments / therapeutic use
  • Phosphatidylinositol 3-Kinase / metabolism*
  • Pruritus / chemically induced
  • Pruritus / complications
  • Pruritus / drug therapy
  • Pruritus / pathology*
  • Quinoxalines / pharmacology
  • Reaction Time / physiology
  • Receptors, Bombesin / metabolism*
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology*
  • Thiazolidinediones / pharmacology
  • p-Methoxy-N-methylphenethylamine / toxicity

Substances

  • 5-quinoxalin-6-ylmethylenethiazolidine-2,4-dione
  • Anticarcinogenic Agents
  • Enzyme Inhibitors
  • Indoles
  • Peptide Fragments
  • Quinoxalines
  • Receptors, Bombesin
  • Thiazolidinediones
  • bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-
  • p-Methoxy-N-methylphenethylamine
  • Gastrin-Releasing Peptide
  • Phosphatidylinositol 3-Kinase
  • PD 176252
  • Bombesin
  • Capsaicin